XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 28, 2024 | (Q4)Dec 28, 2024 | (Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -2.84%12.75B | -1.58%3.12B | -0.68%3.23B | -4.74%3.19B | -4.25%3.2B | 3.71%13.12B | 171.05%3.17B | -17.51%3.26B | -13.28%3.35B | 3.34B |
Operating revenue | -2.84%12.75B | -1.58%3.12B | -0.68%3.23B | -4.74%3.19B | -4.25%3.2B | 3.71%13.12B | 171.05%3.17B | -17.51%3.26B | -13.28%3.35B | --3.34B |
Cost of revenue | -7.18%8.2B | -6.35%1.95B | -4.10%2.06B | -10.01%2.03B | -8.02%2.17B | -0.03%8.84B | 155.09%2.08B | -23.20%2.15B | -17.05%2.26B | 2.36B |
Gross profit | 6.12%4.55B | 7.49%1.18B | 5.95%1.18B | 6.12%1.16B | 4.78%1.03B | 12.39%4.28B | 207.58%1.1B | -3.73%1.11B | -4.29%1.09B | 984M |
Operating expense | -3.82%2.67B | -15.91%645M | 3.45%720M | -1.33%668M | 0.00%638M | 6.85%2.78B | 72.36%767M | -11.34%696M | -7.01%677M | 638M |
Selling and administrative expenses | -3.82%2.67B | -15.91%645M | 3.45%720M | -1.33%668M | 0.00%638M | 6.85%2.78B | 72.36%767M | -11.34%696M | -7.01%677M | --638M |
Operating profit | 24.45%1.87B | 62.20%532M | 10.14%456M | 18.23%493M | 13.58%393M | 24.28%1.51B | 468.54%328M | 12.50%414M | 0.48%417M | 346M |
Net non-operating interest income expense | -53.96%-311M | -537.50%-70M | 0.00%-75M | -13.70%-83M | -18.57%-83M | -20.24%-202M | 184.21%16M | -92.31%-75M | -35.19%-73M | -70M |
Non-operating interest income | ---- | ---- | ---- | ---- | ---- | 206.06%101M | ---- | ---- | ---- | ---- |
Non-operating interest expense | 2.64%311M | -17.65%70M | 0.00%75M | 13.70%83M | 18.57%83M | 50.75%303M | 63.46%85M | 92.31%75M | 35.19%73M | --70M |
Other net income (expense) | 134.98%92M | 97.97%-5M | 133.87%21M | 17.86%33M | 152.94%43M | -86.52%-263M | 25.23%-246M | -214.81%-62M | -53.33%28M | 17M |
Other non- operating income (expenses) | 134.98%92M | 97.97%-5M | 133.87%21M | 17.86%33M | 152.94%43M | -86.52%-263M | 25.23%-246M | -214.81%-62M | -53.33%28M | --17M |
Income before tax | 59.04%1.65B | 366.33%457M | 45.13%402M | 19.09%443M | 20.48%353M | 15.30%1.04B | 122.43%98M | -27.68%277M | -11.64%372M | 293M |
Income tax | 17.83%304M | 116.67%91M | -56.41%34M | 25.97%97M | 34.43%82M | 43.33%258M | 140.78%42M | 5.41%78M | -20.62%77M | 61M |
Earnings from equity interest net of tax | 0.00%6M | 0.00%2M | 300.00%2M | -66.67%1M | --0 | -33.33%6M | -33.33%2M | -133.33%-1M | 50.00%3M | --2M |
Net income | 40.66%1.36B | 1,126.67%368M | 37.04%370M | -4.14%347M | -10.26%271M | 0.21%964M | 130.00%30M | -13.46%270M | 11.04%362M | 302M |
Net income continuous Operations | 72.08%1.36B | 534.48%368M | 86.87%370M | 16.44%347M | 15.81%271M | 7.80%788M | 117.52%58M | -36.54%198M | -8.59%298M | --234M |
Net income discontinuous operations | --0 | --0 | --0 | --0 | --0 | -23.81%176M | ---28M | --72M | --64M | --68M |
Minority interest income | 0.00%13M | 0.00%3M | 200.00%3M | -40.00%3M | 0.00%4M | 550.00%13M | 250.00%3M | -50.00%1M | 5M | 4M |
Net income attributable to the parent company | 41.22%1.34B | 1,251.85%365M | 36.43%367M | -3.64%344M | -10.40%267M | -0.94%951M | 127.55%27M | -13.23%269M | 9.51%357M | 298M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 41.22%1.34B | 1,251.85%365M | 36.43%367M | -3.64%344M | -10.40%267M | -0.94%951M | 127.55%27M | -13.23%269M | 9.51%357M | 298M |
Basic earnings per share | 41.01%3.92 | 1,225.00%1.06 | 35.44%1.07 | -2.88%1.01 | -10.34%0.78 | -1.07%2.78 | 127.59%0.08 | -13.19%0.79 | 8.33%1.04 | 0.87 |
Diluted earnings per share | 40.58%3.88 | 1,200.00%1.04 | 34.62%1.05 | -2.91%1 | -9.30%0.78 | -1.08%2.76 | 127.59%0.08 | -13.33%0.78 | 8.42%1.03 | 0.86 |
Dividend per share | -3.42%2.26 | 1.79%0.57 | -5.00%0.57 | -5.08%0.56 | -5.08%0.56 | 0.00%2.34 | -5.08%0.56 | 1.69%0.6 | 1.72%0.59 | 0.59 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |